| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $259,000 | 1 | 7 |
Sells | $3,130,910 | 13 | 93 |
| Castagna Michael | Chief Executive Officer | 1 | $259,000 | 3 | $1.12M | $-865,456 |
| Singh Sanjay R | EVP Technical Operations | 0 | $0 | 1 | $94,448 | $-94,448 |
| Tross Stuart A | Chief People & Workpl Officer | 0 | $0 | 1 | $297,548 | $-297,548 |
| Binder Steven B. | director | 0 | $0 | 5 | $683,703 | $-683,703 |
| Thomson David | EVP Genl Counsel & Secretary | 0 | $0 | 3 | $930,755 | $-930,755 |
MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of …
Over the last 12 months, insiders at MannKind Corporation have bought $259,000 and sold $3.13M worth of MannKind Corporation stock.
On average, over the past 5 years, insiders at MannKind Corporation have bought $501,422 and sold $2.15M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Castagna Michael (Chief Executive Officer) — $259,000.
The last purchase of 100,000 shares for transaction amount of $259,000 was made by Castagna Michael (Chief Executive Officer) on 2026‑03‑10.
| 2026-09-25 | Sale | Binder Steven B. | director | 39,051 0.0124% | $3.29 | $128,478 | 0.00% | |
| 2026-09-10 | Sale | Binder Steven B. | director | 33,558 0.0109% | $3.81 | $127,856 | -9.63% | |
| 2026-08-07 | Sale | Binder Steven B. | director | 39,051 0.0125% | $4.06 | $158,547 | -9.73% | |
| 2026-07-17 | Sale | Binder Steven B. | director | 52,485 0.0171% | $4.06 | $213,089 | -5.46% | |
| 2026-07-17 | Sale | Thomson David | EVP Genl Counsel & Secretary | 24,109 0.0078% | $4.05 | $97,641 | -5.46% | |
| 2026-05-12 | Sale | Thomson David | EVP Genl Counsel & Secretary | 3,033 0.001% | $3.29 | $9,979 | +16.46% | |
| 2026-05-12 | Sale | Binder Steven B. | director | 16,940 0.0055% | $3.29 | $55,733 | +16.46% | |
| 2026-03-10 | Castagna Michael | Chief Executive Officer | 100,000 0.0314% | $2.59 | $259,000 | +35.63% | ||
| 2026-01-08 | Sale | Tross Stuart A | Chief People & Workpl Officer | 47,006 0.0161% | $6.33 | $297,548 | -39.18% | |
| 2025-12-17 | Sale | Castagna Michael | Chief Executive Officer | 65,804 0.0216% | $6.01 | $395,482 | -37.02% | |
| 2025-12-16 | Sale | Castagna Michael | Chief Executive Officer | 21,310 0.007% | $6.00 | $127,860 | -36.21% | |
| 2025-12-02 | Sale | Castagna Michael | Chief Executive Officer | 107,920 0.035% | $5.57 | $601,114 | -31.31% | |
| 2025-12-02 | Sale | Thomson David | EVP Genl Counsel & Secretary | 147,780 0.048% | $5.57 | $823,135 | -31.31% | |
| 2025-11-14 | Sale | Singh Sanjay R | EVP Technical Operations | 18,777 0.0061% | $5.03 | $94,448 | -23.72% | |
| 2025-09-16 | Sale | Tross Stuart A | Chief People & Workpl Officer | 47,000 0.0152% | $5.34 | $250,980 | -23.46% | |
| 2025-07-16 | Sale | Thomson David | EVP Genl Counsel & Secretary | 7,466 0.0024% | $3.94 | $29,416 | +7.83% | |
| 2025-07-16 | Sale | Binder Steven B. | director | 75,367 0.0247% | $3.94 | $296,946 | +7.83% | |
| 2025-06-10 | Sale | Binder Steven B. | director | 64,085 0.0215% | $4.00 | $256,340 | +4.59% | |
| 2025-05-20 | Sale | Binder Steven B. | director | 12,078 0.004% | $4.40 | $53,143 | +0.46% | |
| 2025-05-20 | Sale | Thomson David | EVP Genl Counsel & Secretary | 2,345 0.0008% | $4.41 | $10,341 | +0.46% |
| Castagna Michael | Chief Executive Officer | 2575911 0.8011% | $9.61M | 21 | 19 | +9.73% |
| Tross Stuart A | Chief People & Workpl Officer | 985007 0.3063% | $3.67M | 12 | 5 | +16.5% |
| Binder Steven B. | director | 713258 0.2218% | $2.66M | 9 | 16 | +22.69% |
| MANN ALFRED E | Chairman & CEO | 74750000 23.2472% | $278.82M | 15 | 0 | <0.0001% |
| Edstrom Hakan | President & CEO | 1060302 0.3298% | $3.95M | 10 | 15 | +11.92% |
| Galindo Alejandro | EVP Endocrine Business Unit | 777090 0.2417% | $2.9M | 6 | 1 | +14.87% |
| HOOPER ANTHONY C | director | 338394 0.1052% | $1.26M | 1 | 0 | +48.09% |
| MUNDKUR CHRISTINE | director | 254493 0.0791% | $949,258.89 | 1 | 0 | +48.09% |
| Grancio Jennifer | director | 244815 0.0761% | $913,159.95 | 1 | 0 | +48.09% |
| KRESA KENT | director | 237589 0.0739% | $886,206.97 | 3 | 0 | <0.0001% |
| McCauley Patrick | Chief Commercial Officer | 100433 0.0312% | $374,615.09 | 5 | 0 | +1.23% |
| Martens Juergen | Corporate VP and COO | 88776 0.0276% | $331,134.48 | 5 | 26 | +0.94% |
| PFEFFER MATTHEW J | director | 82617 0.0257% | $308,161.41 | 10 | 7 | +7.06% |
| ANDERSON RICHARD L | VP & CFO | 48440 0.0151% | $180,681.20 | 2 | 1 | +19.19% |
| Kendall David M | Chief Medical Officer | 41059 0.0128% | $153,150.07 | 5 | 0 | +28.17% |
| Ingram Elizabeth Garrett | Chief Marketing Officer | 31141 0.0097% | $116,155.93 | 1 | 0 | +3.17% |
| Alinaya Rosabel Realica | SVP, Investor Relations | 30091 0.0094% | $112,239.43 | 2 | 1 | +12.28% |
| Barton Courtney | Chief Compl & Privacy Officer | 29584 0.0092% | $110,348.32 | 3 | 0 | +6.05% |
| Palumbo Diane | Vice President, Human Resource | 29105 0.0091% | $108,561.65 | 3 | 27 | <0.0001% |
| Cheatham W Wendell | VP, Chief Medical Officer | 538 0.0002% | $2,006.74 | 2 | 4 | +0.78% |
MannKind Corporation (MNKD) | $831,902,292 | 108 | 9.34% | $1.2B |
$15,410,062 | 81 | 39.69% | $975.93M | |
$54,660,406 | 66 | 22.24% | $1.5B | |
$11,663,618 | 57 | 32.20% | $934.29M | |
$4,431,947 | 22 | 36.10% | $1.46B |
| Increased Positions | 135 | +56.72% | 26M | +15.2% |
| Decreased Positions | 92 | -38.66% | 18M | -10.35% |
| New Positions | 47 | New | 11M | New |
| Sold Out Positions | 24 | Sold Out | 3M | Sold Out |
| Total Postitions | 281 | +18.07% | 181M | +4.85% |
| Blackrock, Inc. | $160,777.00 | 9.35% | 28.71M | -389,822 | -1.34% | 2025-09-30 |
| Vanguard Group Inc | $98,731.00 | 5.74% | 17.63M | -530,280 | -2.92% | 2025-09-30 |
| Rubric Capital Management Lp | $63,922.00 | 3.72% | 11.41M | +11M | New | 2025-09-30 |
| State Street Corp | $60,145.00 | 3.5% | 10.74M | -5,718 | -0.05% | 2025-09-30 |
| Geode Capital Management, Llc | $41,359.00 | 2.41% | 7.39M | -232,070 | -3.05% | 2025-09-30 |
| Nitorum Capital, L.P. | $36,744.00 | 2.14% | 6.56M | -450,050 | -6.42% | 2025-09-30 |
| Ubs Group Ag | $29,091.00 | 1.69% | 5.19M | +3M | +146.67% | 2025-09-30 |
| Avoro Capital Advisors Llc | $25,026.00 | 1.46% | 4.47M | -1M | -23.61% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $22,493.00 | 1.31% | 4.02M | -37,338 | -0.92% | 2025-09-30 |
| Morgan Stanley | $21,563.00 | 1.25% | 3.85M | +1M | +39.6% | 2025-09-30 |